Trial Details
TERMINATEDBasic Information
| Clinical ID | c611 |
|---|---|
| Identifier | NCT02743806 |
| Trial Title | Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative|Crohn Disease |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Garran |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2016-08-01 |
|---|---|
| Primary Completion Date | 2023-01-03 |
| Completion Date | 2023-01-03 |